{"id":53977,"date":"2023-02-16T00:03:17","date_gmt":"2023-02-15T23:03:17","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/"},"modified":"2023-02-16T00:03:17","modified_gmt":"2023-02-15T23:03:17","slug":"omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/","title":{"rendered":"Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023"},"content":{"rendered":"
\n

SANTA CLARA, Calif.–(BUSINESS WIRE)–Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2022, after market on Tuesday, February 28, 2023. The Company will host a conference call and webcast to discuss its financial results at 4:30 p.m. ET that same day.\n<\/p>\n

<\/a><\/p>\n

\nAll interested parties are invited to listen to the live call and presentation by dialing (888) 440-4318 in the U.S. or (267) 764-0566 in international locations. A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell\u2019s website at https:\/\/ir.omnicell.com\/events-and-presentations\/<\/a>.\n<\/p>\n

\nAbout Omnicell<\/b>\n<\/p>\n

\nSince 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Healthcare facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. Institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell’s innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. To learn more, visit www.omnicell.com<\/a>.\n<\/p>\n

\nOMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries.\n<\/p>\n

\nOMCL-E\n<\/p>\n

Contacts<\/b> <\/p>\n

\nKathleen Nemeth
\n
Senior Vice President, Investor Relations
\n
ir@omnicell.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SANTA CLARA, Calif.–(BUSINESS WIRE)–Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2022, after market on Tuesday, February 28, 2023. The Company will host a conference call and webcast to discuss its financial results … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53977","6":"format-standard","7":"category-industry"},"yoast_head":"\nOmnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SANTA CLARA, Calif.–(BUSINESS WIRE)–Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2022, after market on Tuesday, February 28, 2023. The Company will host a conference call and webcast to discuss its financial results ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-15T23:03:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230215005901\/en\/770780\/21\/01_omnicell_lockup_horizontal_green_rgb.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023\",\"datePublished\":\"2023-02-15T23:03:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/\"},\"wordCount\":275,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005901\\\/en\\\/770780\\\/21\\\/01_omnicell_lockup_horizontal_green_rgb.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/\",\"name\":\"Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005901\\\/en\\\/770780\\\/21\\\/01_omnicell_lockup_horizontal_green_rgb.jpg\",\"datePublished\":\"2023-02-15T23:03:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005901\\\/en\\\/770780\\\/21\\\/01_omnicell_lockup_horizontal_green_rgb.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005901\\\/en\\\/770780\\\/21\\\/01_omnicell_lockup_horizontal_green_rgb.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/","og_locale":"en_US","og_type":"article","og_title":"Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 - Pharma Trend","og_description":"SANTA CLARA, Calif.–(BUSINESS WIRE)–Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2022, after market on Tuesday, February 28, 2023. The Company will host a conference call and webcast to discuss its financial results ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-15T23:03:17+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230215005901\/en\/770780\/21\/01_omnicell_lockup_horizontal_green_rgb.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023","datePublished":"2023-02-15T23:03:17+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/"},"wordCount":275,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230215005901\/en\/770780\/21\/01_omnicell_lockup_horizontal_green_rgb.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/","url":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/","name":"Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230215005901\/en\/770780\/21\/01_omnicell_lockup_horizontal_green_rgb.jpg","datePublished":"2023-02-15T23:03:17+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230215005901\/en\/770780\/21\/01_omnicell_lockup_horizontal_green_rgb.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230215005901\/en\/770780\/21\/01_omnicell_lockup_horizontal_green_rgb.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53977"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53977\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}